ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Pyrimidines >Urine (urea) pyrimidine >6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Suppliers list
Company Name: Yancheng KangdiSen Pharmaceutical Co., Ltd.  Gold
Tel: 13812573443;18052965989
Email: tongbenwan22@163.com
Company Name: Shandong Youfu Pharmaceutical Technology Co., Ltd.  Gold
Tel: +86-0536-8226195 +86-13953676784
Email: lee@unipharm-sd.com
Company Name: Anhui Yuanman Chemical Products Sales Co., Ltd.  Gold
Tel: +86-13816842796; 13816814028
Email: xena@yi-mu.com
Company Name: Suzhou Baosheng Pharmaceutical Technology Co., Ltd.,  Gold
Tel: 18616776591
Email: xuchenghao@sinch.com.cn
Company Name: Xiamen Weijia Pharma Co., Ltd  Gold
Tel: 0592-6055939 18950006030
Email: lzf@xmweijia.com

6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione manufacturers

6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Basic information
Uses
Product Name:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione
Synonyms:VITAS-BB TBB000521;6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione 96%;4h)-dione,6-bromo-as-triazine-5(2h;6-BROMO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-3,5-DIONE;6-BROMO-2H-[1,2,4]TRIAZINE-3,5-DIONE;6-BROMO-1,2,4-TRIAZINE-3,5(2H,4H)-DIONE;AURORA 14997;IFLAB-BB F1207-0035
CAS:4956-05-2
MF:C3H2BrN3O2
MW:191.97
EINECS:
Product Categories:Heterocycles series;Halides;Ring Systems;ADVANCED INT.
Mol File:4956-05-2.mol
6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Structure
6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Chemical Properties
Melting point 232-234 °C
density 2.61±0.1 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
pka6.11±0.40(Predicted)
form powder
color Off-white
InChIInChI=1S/C3H2BrN3O2/c4-1-2(8)5-3(9)7-6-1/h(H2,5,7,8,9)
InChIKeyVNTFEWXYAOATFA-UHFFFAOYSA-N
SMILESN1=C(Br)C(=O)NC(=O)N1
CAS DataBase Reference4956-05-2(CAS DataBase Reference)
Safety Information
HS Code 2933998090
MSDS Information
6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Usage And Synthesis
Uses5-Bromo-6-azouridine is mainly used as a pharmaceutical intermediate.
Synthesis2H- [1, 2,4] triazin-3,5-dione (50 g, 442 mmol) is placed in 60 ml of bromine in 800 ml of water at 60°C for 10 h. The reaction medium is then run slowly onto an aqueous ammonia solution until pH = 5. It is then extracted with ethyl acetate and the organic phases are dried over MgS04. After filtration and concentration to dryness, 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione is isolated as a white solid (79.2 g, yield = 93 percent).
References[1] Patent: WO2005/80354, 2005, A1. Location in patent: Page/Page column 19
[2] Patent: US2008/167313, 2008, A1. Location in patent: Page/Page column 7
[3] Patent: WO2004/74266, 2004, A1. Location in patent: Page 52
[4] Patent: WO2006/15985, 2006, A1. Location in patent: Page/Page column 62
[5] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 8, p. 1727 - 1730
6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione Preparation Products And Raw materials
Raw materials6-Azauracil
Preparation Products3,5,6-Trichloro-1,2,4-triazine
Tag:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione(4956-05-2) Related Product Information
4'-Bromoacetophenone 2-Bromoacetophenone Uracil Metribuzin Buprofezin 5-Bromopyrimidine 1,3,5-Triazine Bromine 6-Azauracil 6-AZAURACIL 6-Bromo-2,4-dimethyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione